Epista Life Science named a Sample Vendor in 2021 Gartner® Hype Cycle™ for Life Science Manufacturing, Quality and Supply Chain report

Life Science companies going to the cloud must balance risk and efficiency to achieve more

Epista Life Science is proud to announce our recognition as a Sample Vendor for Compliant GxP Cloud Services in the Gartner Hype Cycle for Life Science Manufacturing, Quality and Supply Chain, 2021¹.

According to the 2021 Hype Cycle report, use of cloud services will have three business impacts.

First, the cloud’s “self-service nature empowers business teams to accelerate business operations as it improves scalability, adds more expansive data capabilities and is a less restrictive use of resources.” Second, “adopting GxP cloud services provides for more efficient use of IT resources and enables a governance-centric operational model.” And third, “large enterprises benefit from flexibility and economies of scale and enable small and midsize businesses lacking expertise and resources to maintain these environments.”

According to this report, “Compliant GxP cloud services enable life science business areas like research, labs, manufacturing and supply chains to more easily leverage the benefits of cloud for hosting a variety of applications and data.”

Klavs Esbjerg, Epista Life Science CEO, is very pleased to receive this recognition. “The benefits of moving to the cloud are many, from increasing flexibility and access to data to simplifying IT management. Yet, the risks are also significant. Moving established processes to the cloud requires balancing trade-offs between adapting the processes or the systems. Release cycles create new opportunities, but also force adaptation. Similarly, increased access to data can create enormous value, and new risks. Epista helps Life Science companies realize the promise of the cloud while managing its risks. By combining our deep experience, proven methodologies, and unique tools, we ensure our clients’ cloud transitions are a success.”

Gartner members can access the full report here.

If you’re ready to move to the Cloud, we’re ready to help. Read more about the proven path to your future platform with Epista’s Pharma Cloud Transition solution.

  1. Gartner, “Hype Cycle for LifeScience Manufacturing, Quality and Supply Chain,” by Michael Shanler & JeffSmith, 20 July 2021.

Gartner Disclaimer

GARTNER and HYPE CYCLE are registered trademarks and service marks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Talk to an expert


Explore other articles

Get in touch

We enjoy sharing our knowledge. Get in touch to find out how Epista can add value to your Life Science company.